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Selenium effects on the metabolism of a
Se-metabolizing Lactobacillus reuteri: analysis of
envelope-enriched and extracellular proteomes†
E. Mangiapane,*a C. Lamberti,b A. Pessione,a E. Galano,c A. Amoresanoc and
E. Pessionea
Selenium (Se) has received great attention in the last few years, as it is considered to be essential for
human health (prevention of viral infections, heart diseases and ageing-related diseases). Se deficiency
can be counteracted by the administration of selenium-enriched probiotics that are able to convert
inorganic selenium into less toxic and more bio-available organic forms. This study was performed on
Lactobacillus reuteri Lb2 BM DSM 16143, a probiotic LAB previously demonstrated to be able to fix Se
into selenocysteines. The aim was to assess Se influence on its metabolism, by a 2-DE proteomic
approach, on two different cellular districts: envelope-enriched and extracellular proteomes. While in
the envelope-enriched fraction 15 differentially expressed proteins were identified, in the extracellular
proteome no quantitative difference was detected. However, at a molecular level, we observed the
insertion of Se into selenocysteine, exclusively under the stimulated conditions. The obtained results
confirmed the possibility to use L. reuteri Lb2 BM DSM 16143 as a carrier of organic Se that can be easily
released in the gut becoming available for the human host.
Introduction
In the post genomic era, the availability of more and more
improved methods for analyzing bacterial sub-proteomes has
shed light on complex physiological phenomena such as the
protein secretion mechanisms,1 energy metabolism,2 quorum
sensing,3 moonlighting proteins,4,5 parallel catabolic path-
ways,6 environmental adaptation7 and detoxification mechan-
isms related to stress.8,9 The analysis of extracellular and
envelope-enriched proteomes can also supply information
about exported virulence factors10,11 useful for developing
suitable diagnostics and therapeutics12 and for discovering
new interesting targets for vaccine development and anti-
microbial chemotherapy.13
As far as commensal and/or probiotic bacteria are con-
cerned, studying extracellular-surface proteomes allows us to
discover proteins involved in bacterial–host cross-talk such as
chaperones and moonlighting glycolytic enzymes,14,15 immune
system modulators16 and proteins involved in adhesion to
biotic surfaces.17–19
In recent years, one of the applications of probiotics is
represented by their use as nutraceutical supplements; they
can be supplemented with zinc, selenium, vitamins and o-3-fatty
acids, in order to enhance beneficial effects on human
health.20,21 Selenium (Se) is a fundamental trace element for
humans, since its deficiency has been correlated to several
diseases (i.e. viral infections, thyroid dysfunctions, different
types of cancer and ageing).22,23 Indeed, Se is essential for
several functions within our cells: it is present as selenocysteine
in 25 selenoproteins that possess antioxidant activity (GPx), and
are involved in redox signaling (TrxR) and thyroid hormone
metabolism (DIO) or in Se transport and storage (SelP).24,25
Furthermore, it has been widely described as a powerful anti-
oxidant and anti-carcinogenic element.26 Therefore, the use of
probiotics as a vehicle of organic selenium forms in human
body represents an interesting perspective in the nutraceutical
field. For this reason, the effects of selenium on probiotic cells
must be deeply studied, in order to elucidate the mechanisms
involved in Se metabolism and to exclude possible harmful
effects.
In a previous paper27 the up-regulation of a selenocysteine lyase,
involved in the selenium-fixing process, has been demonstrated by
in toto proteome analyses in a probiotic LAB: Lactobacillus reuteri
Lb2 BM DSM 16143 grown in a sodium selenite medium.
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The excess of selenite, which could be toxic, undergoes a
reduction to elemental selenium that aggregates generating
particles on the bacterial cell surface.27 More recent results
revealed that the same strain has the capability to specifically
fix inorganic selenium into the selenocysteines of 7 enzymes
involved in different pathways within the cell: glyceraldehyde
3-phosphate dehydrogenase, pyruvate kinase, phosphoketo-
lase, 6-phosphogluconate dehydrogenase, arginine deiminase,
ornithine carbamoyltransferase and ribonucleoside hydrolase
RihC.28
The aim of the present study was to investigate L. reuteri Lb2
BM DSM 16143 sub-proteomes, such as the envelope-enriched
fraction and extracellular compartment, in order to complete
an overall study dealing with the influence of selenium on the
metabolism of this probiotic confirming its potential as a
nutraceutical supplement. For this purpose a 2-DE comparative
proteomic approach was used on cells grown in selenite-
enriched medium and under control conditions without
selenium. To corroborate the proteomic results, a phenotypic
test confirming the role of proteins whose expression was
influenced by selenium has been performed as well.
Experimental
Culture conditions
Lactobacillus reuteri Lb2 BM DSM 16143, belonging to the
collection of BioMan life science S.r.l., was maintained in a
modified MRS (de Man, Rogosa and Sharpe) medium (10 g L1
tryptone enzymatic digest from casein, 8 g L1 peptone from
soybean, 10 g L1 yeast extract, 10 g L1 sucrose, 1 mL L1
tween80, 2 g L1 potassium phosphate dibasic, 5 g L1 sodium
acetate, 2 g L1 ammonium citrate tribasic anhydrous, 0.2 g L1
magnesium sulfate, 0.05 g L1 manganese sulfate) at 24 1C in
0.5 mL aliquots with 0.5 mL of 40% glycerol.
The cultures were grown in closed screw cap bottles, at
37 1C, without shaking. The pH of the medium was adjusted
at 6.4 before the inoculum. The bacterial growth was monitored
by 600 nm optical density (OD600) measurement. L. reuteri Lb2 BM
DSM 16143 was grown under control condition (MRS modified
medium) and under stimulated condition (the same medium
supplemented with 4.38 mg L1 of sodium selenite). A sodium
selenite stock solution (2.19 g L1 corresponding to 1 g L1 of Se)
was prepared and sterilized by filtration (single use syringe filter,
0.20 mm, Sartorius Stedim Biotech) and added to the cold
autoclaved medium.
For all the cultures three biological replicates were made.
Preparation of envelope-enriched protein extracts
Equivalent amounts of cells (150 mg dry weight for each
experiment) were treated in each protein preparation. The cells
were harvested in the exponential growth phase (15 h after the
inoculum). The biomass was collected by centrifugation and
washed in 50 mL 0.85% NaCl. The obtained pellets were
resuspended in 3 mL 50 mM Tris-HCl, pH 7.3, EDTA 1 mM,
sonicated and clarified as previously described.29 To recover the
highest amount of proteins, the pellet was resuspended, soni-
cated and clarified again as already described and the two
supernatants were put together.6 To obtain a fraction enriched
in envelope proteins, the samples were centrifuged (100000  g,
8 h, 4 1C) to pelletize the membrane fragments. Pellets were
solubilized in 20 mM Tris, pH 6.8, 1 mM MgCl2, centrifuged
(45 000  g, 5 h, 4 1C) and resuspended in 200 mL of 50 mM
ammonium bicarbonate. The sample was supplemented with
1 mL of 2 : 1 v/v trifluoroethanol/chloroform and incubated at
0 1C for 1 h, vortexing it for 10 s every 5 min. By centrifuging
(10 000  g, 5 min, 4 1C) this suspension, an upper aqueous
phase, an insoluble interphase and a lower chloroformic phase
were obtained. The upper phase was recovered and dried using a
vacuum centrifuge.6,30,31 The residue was solubilized in rehydration
solution (6.5 M urea, 2.2 M thiourea, 1% w/v aminosulfobetaine-14,
5 mM Tris-HCl, pH 8.8, 0.5% IPG buffer (GE Healthcare),
100 mM DTT) and proteins were quantified by the 2-D quant
kit (GE Healthcare) and Bradford assay.
Preparation of extracellular protein fraction
The samples were prepared as previously described by Mangia-
pane et al.32 Briefly, middle exponential phase cultures were
centrifuged (4000  g, 20 minutes, 4 1C, Thermo Scientific SL
16R) and the obtained supernatants were filtered using Steri-
cup filters (Millipore), in order to eliminate the biomass.
Trichloroacetic acid 16% w/v was added to promote protein
precipitation under shaking over night at 4 1C. The obtained
suspensions were then ultracentrifuged (35 000  g, 90 min,
4 1C). Pellets were dried, pulverized and resuspended in 50 mM
Tris-HCl pH 7.3. 1 mL aliquots of the obtained sample were
subjected to phenol extraction as described before.11 One mL
phenol was added and the mixtures were incubated for 10 min
at 70 1C and for 5 min at 0 1C and centrifuged (7000  g,
10 min, room temperature). The upper phase was discarded
and 1 mL of MilliQ water was added to the lower phase, which
was then incubated for 10 min at 70 1C and for 5 min at 0 1C
and centrifuged (7000  g, 10 min, room temperature) again.
The upper phase was discarded and 1 mL of ice cold acetone
was added to the lower phase before incubating over night at
20 1C. Precipitated proteins were recovered by centrifuging
(15 000  g, 20 min, 4 1C) and washed with ice cold acetone
(15 000  g, 20 min, 4 1C). Pellets were pulverized and resus-
pended in rehydration solution and proteins were quantified by
the 2-D quant kit (GE Healthcare) and Bradford assay.
2-DE
IEF (Isoelectrofocusing) was performed as previously described.29
The proteins were separated into 13 cm IPG strips (GE Healthcare)
with a linear gradient ranging from 4 to 7: 235 mg of proteins were
loaded for the envelope-enriched protein fraction, while 275 mg for
the extracellular proteome. IEF was performed using IPGphor (GE
Healthcare) at 20 1C, with 66000 Vh (envelope-enriched protein
fraction) and 83000 Vh (extracellular fraction). After IEF, the strips
were incubated at room temperature in 6 M urea, 30% v/v glycerol,
2% w/v SDS, 50 mM Tris-HCl, pH 8.6, enriched at first with 2% w/v
DTT for 15 min and afterwards with 4.5% w/v iodoacetamide
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for 15 min. They were then sealed at the top of the 1.0 mm
vertical second dimension gels. For each sample, SDS-PAGE
was carried out on 11.5% T and 3.3% C acrylamide (Biorad
Acrylamide) homogeneous gels. The running buffer was 25 mM
Tris, 192 mM glycine, 0.1% SDS. The running conditions were
11 1C, 600 V constant voltage, 20 mA per gel, 60 W for 15 min
and 11 1C, 600 V constant voltage, 40 mA per gel, 80 W for about
2.5 h. The molecular weight markers were from the Low
Mr Electrophoresis Calibration Kit (GE-Healthcare). The gels
were automatically stained using Processor Plus (Amersham
Biosciences) with freshly prepared Neuhoff stain (Colloidal
Coomassie Blue)33 and, after image acquisition, they were dried
in a GD 2000 Vacuum Gel Drier System (GE Healthcare).
Image analysis and statistical analysis
2-DE gels were digitized using Personal Densitometer SI
(Amersham Biosciences). Image analysis and spot detection
were performed with Progenesis PG200 software (Non Linear
Dynamics). Spot detection was automatically performed by
using the algorithm named ‘‘2005 detection’’ and manually
checked. After the establishment of some user seeds, matching
was automatically performed andmanually verified. For both the
envelope-enriched and the extracellular fractions, two analytical
replicates for each of the three biological replicates were used.
Spot intensities were measured via normalized spot volumes and
were statistically analyzed bymeans of the t-test: the mean values
were considered significantly different when p o 0.05. All the
spots with po 0.05 and present in at least five out of six replicates
identified were selected for MS identification.
Protein identification
Enzymatic digestion was carried out with 200 ng of trypsin in
50 mL of 10 mM NH4HCO3 buffer, pH 7.8. Gel pieces were
incubated at 37 1C overnight. Peptides were then extracted by
washing the gel particles with 10 mM NH4HCO3 and 1% formic
acid in 50% ACN at room temperature. The resulting peptide
mixtures were filtered using a 0.22 PVDF filter from Millipore.
The peptide mixtures were analysed by nanoLC-chip MS/MS,
using a CHIP MS 6520 QTOF equipped with a capillary 1200
HPLC system and a chip cube (Agilent Technologies). After
loading, the peptide mixture (8 mL in 0.1% formic acid) was first
concentrated and washed at 4 mL min1 in 40 nL enrichment
column (Agilent Technologies chip), with 0.1% formic acid as
an eluent. The sample was then fractionated on a C18 reverse-
phase capillary column (75 mm  43 mm in the Agilent
Technologies chip) at a flow rate of 400 nL min1 with a linear
gradient of eluent B (0.1% formic acid in 95% ACN) in A (0.1%
formic acid in 2% ACN) from 7 to 60% for 50 min. Doubly and
triply charged peptides were selected and analyzed using data-
dependent acquisition of one MS scan (mass range from 300 to
2000 m/z) followed by MS/MS scans of the three most abundant
ions in each MS scan. Collision energy (CE) applied during
peptide fragmentation is calculated by the subsequent empirical
equations: CE = 4 V/100 Da  2.4 V. Raw data from nanoLC-MS/
MS were analyzed and converted in common spectral file formats
(.mgf mascot generic file), using Qualitative Analysis software
(Agilent MassHunter Workstation Software, version B.02.00).
MASCOT software (www.matrixscience.com) version: 2.4.0 was
used for the protein identification against the NCBInr database
(NCBInr_20120920.fasta; 21582400 sequences; 7401135489 resi-
dues), with the taxonomy restriction to Other Firmicutes (2926062
sequences). The MASCOT search parameters were: ‘‘trypsin’’ as
enzyme allowing up to 3 missed cleavages, carbamidomethyl on
cysteine residues as fixed modification, oxidation of methionine
and formation of pyroGlu N-term on glutamine were selected as
variable modifications, 10 ppm MS/MS tolerance and 0.6 Da
peptide tolerance. By data analysis, the threshold provided to
evaluate quality of matches for MS/MS data was found to be 41.
Bile resistance experiment
Four different cultures were set up: L. reuteri Lb2 BM DSM
16143 was grown in MRS medium, MRSmedium supplemented
with 4.38 mg L1 sodium selenite, MRS medium supplemented
with 0.5% bile salts (Sigma Aldrich) and MRS medium supple-
mented with both sodium selenite and bile salts. An over-night
pre-culture was used to perform the inoculation at 0.1% and
after 5 hour growth the number of colony forming units per mL
(CFU per mL) was determined by plating serial 10-fold dilutions
onto MRS agar. For all the four cultures two different biological
replicates were performed.
Results and discussion
Expression pattern of the envelope-enriched protein fraction
under Se-fortified and Se-free conditions
Comparative proteomic analyses in the acidic (4–7) pI range
were performed on the envelope-enriched protein fraction to
detect the differentially expressed proteins between control
(MRS modified medium) and stimulated (MRS + 4.38 mg L1
Na2SeO3) conditions. Maps are shown in Fig. 1.
The image analysis revealed 15 differentially expressed
spots: 10 were up-regulated by Se (phosphoketolase, spot 1;
phosphoketolase, spot 2; 6-phosphogluconate dehydrogenase,
spot 3; bifunctional acetaldehyde-CoA/alcohol dehydrogenase,
spot 4; molybdopterin biosynthesis protein MoeA, spot 5;
choloylglycine hydrolase, spot 6; F0F1 ATP synthase subunit
beta, spot 7; elongation factor Tu, spot 8; tRNA/rRNA methyl-
transferase (SpoU), spot 9; ATP-dependent Clp protease proteo-
lytic subunit, ClpP, spot 10) and 5 were down-regulated by Se
(diol/glycerol dehydratase reactivating factor, large subunit,
spot 11; dehydratase, medium subunit, spot 12; a-enolase,
spots 13 and 14; ornithine carbamoyltransferase, spot 15).
All of them were identified by nanoLC-chip MS/MS (Table 1;
Table S1, ESI†). Fig. 2 shows the average normalized volumes
and their variations under the two experimental conditions for
each spot.
A very interesting enzyme up-regulated in selenium is
molybdopterin biosynthesis protein MoeA (spot 5) that is
involved in the synthesis of molybdenum cofactor (Moco) in
all Mo-dependent enzymes in bacteria. Moco consists of a
molybdopterin (MPT) compound that coordinates a Mo atom.34
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MoeA is actually responsible for the insertion of Mo into MPT in
order to obtain the activated form of the cofactor.35 Mo-cofactor
containing enzymes are named Mo hydrolases (MH): this family
includes selenium-dependent molybdenum hydroxylases (SDMH)
which contain a labile selenium atom, probably not contributed
by SeCys, but through some other mechanisms. These enzymes
are present in species also carrying the SelD protein (specifically
involved in the production of selenophosphate, the activated
form of Se), suggesting its involvement in the activation of Se
for SDMHmaturation.36 In a study by Srivastava and coworkers,37
an eubacterial gene cluster that links selD with a gene encoding a
molybdenum hydroxylase has been described. In other anaerobic
and facultative microorganisms, other genes, probably involved in
Se metabolism and Mo cofactor synthesis, co-localize with this
group. This specific cluster is present in a lactic acid bacterium,
Enterococcus faecalis,37 suggesting the possibility that the same
scenario can occur in other LABs, such as L. reuteri. MoeA
up-regulation is therefore probably linked to the expression in
L. reuteri Lb2 BM of Se-dependent molybdenum hydroxylases,
even if no SDMH has been identified in this study.
The up-regulation of F0F1 ATP synthase subunit beta (spot 7)
is consistent with the results already obtained for the in toto
proteome27 in which the ATP synthase F1 epsilon subunit has
been observed to be over-expressed in selenium. The beta
subunit identified in this work is part of the F1 catalytic core
and it is responsible for ATP synthesis.38 The F0F1 complex is
present at the membrane level, confirming the efficacy of the
protocol used to recover proteins. Furthermore this result is in
agreement with the observed stimulation of the energy-
generating routes (glycolysis and pentose-phosphate pathway)
resulting in enhanced ATP synthesis.27
Elongation factor Tu (spot 8) is up-regulated under the
stimulated conditions. This protein, normally present in the
cytosol and involved in protein synthesis, is described as a
moonlighting protein, since it is responsible for adhesion when
surface-exposed. EF–Tu has also been detected in the exopro-
teome of Bifidobacterium animalis subsp. lactis as putative
moonlighting protein with adhesion roles that contribute to the
probiotic features of the strain.39 In the literature EF–Tu involve-
ment in adhesion processes is well documented: in Mycoplasma
Table 1 List of the identified spots from the envelope-enriched protein fraction after nanoLC-chip MS/MS. For each protein number of peptides, score
and percentage of sequence coverage are reported
Spot MW (Da) Identified protein NCBInr ID
No. of
peptides Score
Sequence
coverage (%)
1 91 374 Phosphoketolase gi|194467185 70 1695 58
2 91 374 Phosphoketolase gi|194467185 33 798 47
3 53 498 6-Phosphogluconate dehydrogenase gi|184154309 19 394 32
4 97 640 Bifunctional acetaldehyde-CoA/alcohol dehydrogenase gi|148543558 15 451 15
5 44 850 Molybdopterin biosynthesis protein MoeA gi|184153597 8 276 20
6 36 082 Choloylglycine hydrolase gi|148543961 26 861 76
7 51 600 F0F1 ATP synthase subunit beta gi|148543702 29 1100 51
8 43 405 Elongation factor Tu gi|148543883 24 700 47
9 28 292 tRNA/rRNA methyltransferase SpoU gi|148544445 35 945 86
10 21 420 ATP-dependent Clp protease proteolytic subunit gi|148543625 39 1227 85
11 65 655 Diol/glycerol dehydratase reactivating factor, large subunit gi|148544950 55 1857 72
12 25 849 Dehydratase, medium subunit gi|148544952 9 350 32
13 48 010 Phosphopyruvate hydratase gi|194468183 18 619 37
14 48 010 Phosphopyruvate hydratase gi|194468183 56 1856 73
15 37 536 Ornithine carbamoyltransferase gi|148543661 33 1006 83
Fig. 1 Envelope-enriched protein fraction maps of L. reuteri LB2 BM DSM 16143 grown under control and stimulated conditions in the acidic
(4–7) pI range. Fifteen spots were differentially expressed between the two conditions.
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pneumoniae EF–Tu binds to fibronectin,40 and in Lactobacillus
johnsonii it is able to bind mucin and thus intestinal epithelial
cells, also displaying immunomodulatory properties.17
Another interesting up-regulated enzyme is bifunctional
acetaldehyde-CoA/alcohol dehydrogenase (spot 4). This protein
is made up of two conserved domains (Aldh and Adh), it is
NADH-dependent, and it is involved in the two-step sequential
conversion of acetyl-CoA to ethanol as an end product of
fermentation.41 A few bacteria are known to catalyze these
two reactions sequentially among which Streptococcus bovis42
and Clostridium acetobutylicum.43 In acetic acid bacteria this
enzyme is membrane-bound and it is composed of three sub-
units with different molecular masses (72–80 kDa, 44–54 kDa,
8–20 kDa).44 On the basis of the protein spot position in the
obtained 2-DE maps of L. reuteri Lb2 BM DSM 16143, it is
possible to assert that the identified subunit is probably the
intermediate molecular mass component. The up-regulation of
this enzyme in the heterofermenter L. reuteri is consistent with
the over-expression of phosphoketolase (spot 1, 2) and of both
glycolysis and pentose phosphate pathway previously demon-
strated in selenium-fortified media,27 since bifunctional
acetaldehyde-CoA/alcohol dehydrogenase is at the end of
the fermentation process, allowing conversion of acetate into
ethanol, the second main product of heterofermenters. The
correlation between these two proteins has also been confirmed
by an interactome bioinformatic analysis performed with
STRING 9.05 with a score of 0.557 (medium confidence).
The over-expression of the ATP-dependent Clp protease
proteolytic subunit, ClpP, (spot 10) suggests a stress-response
in L. reuteri Lb2 BM grown in selenium. It has been previously
demonstrated that the growth on selenium can cause a certain
degree of stress in L. reuteri: GroEL and GrpE, two well known
stress protein, were up-regulated in the presence of 4.38 mg L1
sodium selenite.27 ClpP is a serine protease that degrades small
peptides (o7 amino acids). In Lactococcus lactis ClpP is
involved in the degradation of misfolded proteins originated
after stress exposure.45 ClpP protease gene has been demon-
strated to be induced under stress conditions (stationary phase
and ethanol stress) also in the LAB Oenococcus oeni by real-time
reverse transcription-PCR analysis46 and to be regulated during
heat stress in L. plantarum by proteomic studies.47
Among selenium up-regulated proteins, choloylglycine
hydrolase (spot 6) represents an interesting enzyme since it
catalyzes the initial ‘‘gateway’’ reaction in the bacterial meta-
bolism of CBAs (conjugated bile acids): the reaction consists in
a deconjugation of CBAs to liberate free primary bile acids (BAs;
cholic acid or chenodeoxycholic acid) and amino acids.48 CBAs
have been suggested to repress bacterial growth in the small
intestine by means of direct antimicrobial effects, up-regulation
of host mucosal defenses, or synergistic action of both mechan-
isms.49 Choloylglycine hydrolase has widely been reported to be
exposed on the surface of several Gram positive bacteria, such
as Clostridium perfringens50 and Bifidobacterium lactis BI07,
where it is responsible for Plg-binding.14 The expression and
up-regulation of this enzyme by L. reuteri Lb2 BM DSM 16143
have a great importance for its probiotic traits, suggesting both
the ability of the strain to survive to CBAs action and also a
positive role of selenium in enhancing bile-salt survival. In
order to confirm this capacity and to understand the effect of
selenium on this phenomenon, the resistance to bile salts has
been tested under both conditions (with and without Se). As
shown in Fig. 3, a real increment of the resistance ability of
L. reuteri Lb2 BM to bile salts in the presence of selenium was
observed: 30% of survival with Se versus 17% without Se. In the
literature there is no evidence of a link between bile salt
resistance and selenium; however, such a capacity can encourage
the use of this strain, grown in the presence of selenium, as a good
probiotic in general and especially to treat hypercholesterolemic
Fig. 2 For each identified protein average normalized volumes and their variations (SEM = standard error of the mean) under the two experimental
conditions are shown.
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subjects. Indeed, since deconjugated bile acids are not well
absorbed by the gut mucosa and are excreted with feces, new
cholesterol is driven from blood to liver for de novo CBA
synthesis,51 allowing a reduction of blood cholesterol levels.
The down-regulated ornithine carbamoyltransferase (OTC,
spot 15) is a very interesting protein. This enzyme is involved in the
energy- and ammonia-generating ADI pathway and catalyzes the
conversion of citrulline into carbamoyl-phosphate and ornithine.
Its down-regulation is consistent with the previous finding of a
Se-induced down-expression of other two enzymes belonging to
ADI pathway, namely arginine deiminase and carbamate kinase.27
These results corroborate the suggestion of the need for the
acidophilic L. reuteri to control the entire operon to attenuate
NH3-induced toxicity, since it is meanwhile involved to cope with
stress induced by selenium. Interestingly OTC was found in the
envelope-enriched fraction as well as on the surface of Clostridium
perfringens,50 and the opportunistic Staphylococcus epidermidis.52 If
we consider the physiological role of ADI, we find that this route is
coupled with an antiport system ensuring new arginine supply
inside the cell by exchanging the OTC-generated ornithine. The
presence of this OTC enzyme in the proximity of the ornithine/
arginine antiporter (i.e. membrane) can constitute an advantage
for L. reuteri Lb2 BM physiology, by facilitating substrate supply to
the antiport system.
Expression pattern of the extracellular protein fraction under
Se-fortified and Se-free conditions
The comparative proteomic analysis of the extracellular frac-
tion of L. reuteri Lb2 BM DSM 16143 revealed that selenium
does not induce quantitative differences in protein expression
(Fig. 4). For this reason, we focused our attention exclusively on
the map deriving from Se-grown cultures. In these maps, image
analysis revealed 59 spots that were then identified by nano-
LC-chip MS/MS as 21 different proteins (considering isoforms).
Fig. 3 Effects of selenium supplementation on bile salt resistance. CFU
number without treatment of bile salts was considered as a positive
control (100% growth) both in the presence and absence of selenium.
The survival percentage after treatment of bile salts is reported under both
the tested conditions. The percentages were calculated as the mean
values between the two biological replicates.
Fig. 4 Extracellular protein fraction map of L. reuteri LB2 BM DSM 16143 grown in the presence of sodium selenite in the acidic (4–7) pI range.
Spots corresponding to proteins in which selenocysteines were identified are in the thicker boxes (spots 8 and 19).
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These proteins are the same as those already described in
a recent paper of our group32 in which we considered only
extracellular proteins derived from cultures without selenium.
Identified proteins have been divided into three func-
tional groups: (1) cell wall processing enzymes (spot 1,
mannosyl-glycoprotein endo-beta-N-acetylglucosamidase and
N-acetylmuramoyl-L-alanine amidase; spot 2, peptidoglycan-
binding LysM; spot 3, NLP/P60 protein; spot 4, peptidoglycan-
binding LysM; spot 5, unknown extracellular protein lr1267;
spot 6, Apf1-like protein); (2) adhesion-involved proteins
(spot 7, phosphopyruvate hydratase (a-enolase); spot 8, glycer-
aldehyde 3-phosphate dehydrogenase; spot 9, elongation
factor Tu; spot 10, elongation factor Ts; spot 11, molecular
chaperone DnaK; spot 12, phosphoglycerate kinase; spot 13,
phosphoglyceromutase; spot 14, trigger factor); (3) other pro-
teins (spot 15, dextransucrase; spot 16, sucrose phosphory-
lase; spot 17, mannitol dehydrogenase; spot 18, alcohol
dehydrogenase; spot 19, phosphoketolase; spot 20, hypo-
thetical protein Lreu_0552, spot 21, ribosome recycling
factor). Since in a recent paper we proved28 the ability of the
strain to fix selenium into seven proteins in the form of
selenocysteine (SeCys, U), the presence of selenopeptides in
the extracellular secreted proteins from selenium-grown bacteria
was manually checked in the raw data of the LC-MS/MS. This
analysis revealed the presence of two peptides containing a SeCys
and belonging, respectively, to glyceraldehyde 3-phosphate
dehydrogenase (spot 8, NDGVDFVLEUTGFYTSAEK) and phos-
phoketolase (spot 19, NQEUINLFVTSK) (Fig. 5).
Phosphoketolase has been observed to be induced in both
in toto proteome27 and cell-envelope enriched proteome, and
identified in this experiment analyzing extracellular proteome.
It probably belongs to the so-called moonlighting proteins that
display the ability to be present in different cellular districts.53
To this class belongs GAPDH as well. This glycolytic enzyme,
when extracellularly-exposed or released can act as an adhe-
sine, since it is able to bind extracellular matrix proteins.54
It can be hypothesized that this enzyme could act as a sele-
nium storage protein, as already suggested by Ogasawara and
co-workers.55
Both glyceraldehyde 3-phosphate dehydrogenase and phos-
phoketolase were already identified in the in toto proteome28 as
selenocysteine-containing proteins: this result corroborates
once more the ability of the strain to fix selenium generating
organic Se-forms and can explain the previously reported
increase of Se concentration in the external medium after
about 6 hours of growth.28 Furthermore, the fact that SeCys-
containing proteins are released in the extracellular environ-
ment before cell lysis is an added value for a probiotic strain
to be employed as a nutraceutical, since this mechanism
increases selenium bioavailability in the human gut. In fact it
has to be considered that only organic Se forms (selenocysteine
and/or selenomethionine) can be metabolized and assimilated
by humans without inducing toxic effects, actually representing
the most bio-available form for human body.
Conclusions
Lactobacillus reuteri Lb2 BM DSM 16143 has been widely
characterized for its ability to accumulate and metabolize
selenium, with the final purpose to produce a nutraceutical
supplement to be employed in the treatment of Se-deficiency.
In this scenario, the use of comparative proteomic in different
subcellular districts allowed us to have an overall picture of the
effects of Se on bacterial physiology. In this study, in particular,
the obtained results corroborate what described by our group in
previous papers: (i) Se induces energy production through
glycolysis and the pentose phosphate pathway at the expense
Fig. 5 Manual search of the selenocysteine-containing peptide NQEUINLFVTSK after interpretation of the MS/MS spectrum of the double charged ion
of phosphoketolase at m/z 750.83.
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of the ADI pathway; (ii) Se causes a slight stress response
represented by the up-regulation of chaperones and stress
proteins; (iii) it is interesting to underline the presence of SeCys
residues in phosphoketolase and GAPDH in both the in toto
and extracellular proteome, suggesting a Se-storage function.
The detection of SeCys in secreted proteins confers an added
value since the host receives organic Se forms both during
bacterial life in the human gut and once more after cell lysis.
Furthermore, Se seems to increase the probiotic potential of
L. reuteri Lb2 BM DSM 16143; indeed, the up-regulation of
choloylglycine hydrolase and the subsequent phenotypic analyses
allowed us to demonstrate a positive effect of Se on the survival to
bile salts. Even if the mechanisms of this phenomenon remain
unknown, it is an appreciated ability since it guarantees the
survival of the strain during the gastrointestinal transit.
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